Literature DB >> 32494926

Biomarkers in the ICU: less is more? Not sure.

Pedro Póvoa1,2,3, Jorge I F Salluh4,5, Thiago Lisboa6,7,8.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32494926     DOI： 10.1007/s00134-020-06077-4

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  12 in total

1.  Dear Sirs, what is your PCT?

Authors:  J L Vincent; D Mercan
Journal:  Intensive Care Med       Date:  2000-09       Impact factor: 17.440

Review 2.  Serum markers in community-acquired pneumonia and ventilator-associated pneumonia.

Authors:  Pedro Póvoa
Journal:  Curr Opin Infect Dis       Date:  2008-04       Impact factor: 4.915

3.  Circulating biomarkers may be unable to detect infection at the early phase of sepsis in ICU patients: the CAPTAIN prospective multicenter cohort study.

Authors:  Marianna Parlato; François Philippart; Alexandra Rouquette; Virginie Moucadel; Virginie Puchois; Sophie Blein; Jean-Pierre Bedos; Jean-Luc Diehl; Olfa Hamzaoui; Djillali Annane; Didier Journois; Myriam Ben Boutieb; Laurent Estève; Catherine Fitting; Jean-Marc Treluyer; Alexandre Pachot; Minou Adib-Conquy; Jean-Marc Cavaillon; Benoît Misset
Journal:  Intensive Care Med       Date:  2018-06-30       Impact factor: 17.440

4.  Dear SIRS, I'm sorry to say that I don't like you...

Authors:  J L Vincent
Journal:  Crit Care Med       Date:  1997-02       Impact factor: 7.598

Review 5.  A review of novel technologies and techniques associated with identification of bloodstream infection etiologies and rapid antimicrobial genotypic and quantitative phenotypic determination.

Authors:  Stephen Poole; Stephen P Kidd; Kordo Saeed
Journal:  Expert Rev Mol Diagn       Date:  2018-06-07       Impact factor: 5.225

Review 6.  The current status of biomarkers for the diagnosis of nosocomial pneumonias.

Authors:  Jorge I F Salluh; Vicente C Souza-Dantas; Pedro Póvoa
Journal:  Curr Opin Crit Care       Date:  2017-10       Impact factor: 3.687

Review 7.  Biomarker-guided antibiotic therapy-strengths and limitations.

Authors:  David Nora; Jorge Salluh; Ignacio Martin-Loeches; Pedro Póvoa
Journal:  Ann Transl Med       Date:  2017-05

8.  A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis.

Authors:  Nathan I Shapiro; Stephen Trzeciak; Judd E Hollander; Robert Birkhahn; Ronny Otero; Tiffany M Osborn; Eugene Moretti; H Bryant Nguyen; Kyle J Gunnerson; David Milzman; David F Gaieski; Munish Goyal; Charles B Cairns; Long Ngo; Emanuel P Rivers
Journal:  Crit Care Med       Date:  2009-01       Impact factor: 7.598

9.  Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000.

Authors:  John C Marshall; Jean-Louis Vincent; Mitchell P Fink; Deborah J Cook; Gordon Rubenfeld; Debra Foster; Charles J Fisher; Eugen Faist; Konrad Reinhart
Journal:  Crit Care Med       Date:  2003-05       Impact factor: 7.598

10.  Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review.

Authors:  Pedro Póvoa; Jorge I F Salluh
Journal:  Ann Intensive Care       Date:  2012-07-23       Impact factor: 6.925
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.